Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Talphera Inc (TLPH)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Talphera's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.9700 +0.0241    +2.55%
16:00:00 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 32,183
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.9500 - 1.0500
Talphera 0.9700 +0.0241 +2.55%

Talphera Inc Company Profile

 
Get an in-depth profile of Talphera Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

15

Equity Type

ORD

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.

Contact Information

Address 1850 Gateway Drive Suite 175
San Mateo, 94404
United States
Phone 650 216 3500
Fax -

Top Executives

Name Age Since Title
Mark Allen Wan 58 2006 Independent Director
Adrian Adams 73 2013 Independent Chairman
Vincent J. Angotti 56 2017 CEO & Director
Stephen J. Hoffman 70 2010 Independent Director
Mary Southam - - Member of Medical Advisory Board
Eugene R. Viscusi - - Member of Medical Advisory Board
Abhinav Jain 32 2024 Director
Jill M. Broadfoot 62 2021 Independent Director
Jonathan Schaffer - - Member of Medical Advisory Board
William K. Schmidt 73 - Member of Medical Advisory Board
Katsuto Shinohara - - Member of Medical Advisory Board
Marina S. Bozilenko 59 2021 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TLPH Comments

Write your thoughts about Talphera Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Arend Wolven
Arend Wolven Nov 06, 2023 2:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
First ENTRY 0.4728
Andres Tarra
Andres Tarra May 26, 2023 10:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what's going on here?
Bradley Diermeier
Bradley Diermeier Apr 18, 2023 7:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this trash stock showing signs of life?
Mauro Miche
Mauro Miche Jan 09, 2023 8:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hi, NEWS?
Vitalik Khudeev
Vitalik Khudeev Jul 06, 2022 4:35PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wow
Ludo Huibers
Ludo Huibers Jun 15, 2022 11:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wooo...sp up to 0.21999...did somebody buy 5 stocks at 0.22?lmao...what a scam
Ludo Huibers
Ludo Huibers Jun 14, 2022 11:21AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
acxr is a more appropriate name for this garbage
Ludo Huibers
Ludo Huibers May 26, 2022 12:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what a joke this scam
Ludo Huibers
Ludo Huibers May 03, 2022 3:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
earnings better be astonishing...else game over!
Bradley Diermeier
Bradley Diermeier Dec 15, 2021 9:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good news today for this garbage stock???
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email